DKK1 and neoplasm: DKK1 has been shown to be overexpressed and associated with worse outcomes in a number of cancers42 and in addition to WNT signalling pathway modulation, DKK1 may affect tumour immunity through direct actions on NK cells or MDSCs.24, 25, 26